Major Market Shift in Ticovac Industry: Suspension Formulation Boosts Competitive Edge In The Ticovac Market

What Are the Market Size and Growth Forecast for the Ticovac Market?
The market size for Ticovac has significantly expanded in the past years. The growth is expected to continue, going from $4,010 million in 2024 to $4,310 million in 2025, increasing at a compound annual growth rate (CAGR) of 7.6%. Factors such as heightened awareness, an increase in travel to endemic regions, escalating veterinary issues, a growing elderly population, and increases in military and defense vaccinations have all contributed to this historic period growth.

Expectations are for the Ticovac market to witness significant growth in the coming years. By 2029, it's predicted to root itself at a value of $5,700 million with a compound annual growth rate (CAGR) of 7.3%. This projected growth during the forecast duration is due to several factors such as a rise in outdoor workers, enhanced healthcare expenditure, escalating emphasis on controlling region-specific diseases, expansion in health insurance coverage, and an increase in the occurrence of tick-borne encephalitis (TBE) cases. The forecast period will also likely highlight key trends such as technological advancements in manufacturing vaccines, the launch of new TBE vaccines, partnerships between governments and pharmaceutical firms, progress in genetic studies, and improvements in after-care post-vaccination.

What Is Contributing to the Growth of the Ticovac Market?
The increasing incidence of tick-related illnesses is projected to fuel growth within the ticovac market. Tick-borne diseases, caused by bacteria, viruses, or parasites, are passed to humans via bites from infected ticks. Due to factors such as climate change, expanded tick habitats, enhanced human exposure, and improved diagnostics, the occurrence of these diseases is on the rise. The ticovac vaccine, which offers active immunity against tick-borne encephalitis (TBE), is essential for combatting these diseases. For instance, the Centers for Disease Control and Prevention reported in February 2024 that the prevalence of Lyme disease had risen to 18.9 cases per 100,000 population, a 68.8% increase from previous years. With high-incidence areas experiencing a 58% increase to 68.3 cases per 100,000, and the 5-9 year age group seeing an incidence of 16.5 cases per 100,000, an increase of 11.5%, the ticovac market is set to grow as the prevalence of tick-borne diseases continues to rise. The ticovac market is also expected to benefit from increased research and development activities. Such activities, which include systematic investigations and innovative efforts aimed at improving existing products or developing new technologies, are essential for driving progress within various industries. The rise in research and development activities is linked to a growing demand for innovation and the need to tackle new global challenges. These activities also facilitate improvements in TicoVac's vaccine formulation, enhancing its effectiveness and readiness to combat emerging strains of tick-borne encephalitis. For instance, according to the UK's Department of Health and Social Care, the business enterprise sector spent $11.3 billion (£9.0 billion) on pharmaceutical research and development in 2022, accounting for 0.36% of the UK's GDP. This constituted 18% of all business-led R&D in the UK for that year, representing the highest share across all sectors. As such, the growing research and development activities are spurring further growth in the ticovac market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19939&type=smp

Which Key Market Leaders Are Driving Ticovac Industry Growth?
Major companies operating in the ticovac market include Pfizer Inc.

What Are the Emerging Trends in the Ticovac Industry?
One major trend observed in the ticovac market is the emphasis on developing creative formulations like suspension liquid to acquire a competitive advantage in the sector. Suspension liquid serves as a vaccine formulation structured for tick-borne encephalitis prevention, and it is applicable for intramuscular injection. It is offered in a 0.5 mL dose made compatible for adults and children. For instance, Pfizer Inc., a renowned pharmaceutical manufacturer in the US, introduced Ticovac to the market in September 2024. This vaccine was developed to prevent tick-borne encephalitis (TBE), a brain and spinal cord viral infection. This was the first vaccine of its kind in Japan, providing protection against the disease in areas of its prevalence. The vaccine comes in two versions, one aimed at adults and another for children, as a 0.5 mL intramuscular injection.

What Are the Main Segments in the Ticovac Market?
The ticovacmarket covered in this report is segmented -

1) By Formulation: Inactivated Vaccines; Live Attenuated Vaccines
2) By Indication: Tick-Borne Encephalitis; Japanese Encephalitis; Rabies Encephalitis
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/ticovac-global-market-report-

Which Geographic Area Leads the Ticovac Market?
Europe was the largest region in the ticovac market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the ticovac market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Ticovac Global Market Report?

- Market Size Analysis: Analyze the ticovac Market Size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the ticovac market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall ticovac market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the ticovac market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19939

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.